Part
01
of one
Part
01
Diseases Prevalence and Cost of Treatment
Key Takeaways
- Obesity and Atrial Fibrillation have low undiagnosed rates as their symptoms are easily noticeable. However, diseases with less common symptoms have a higher diagnoses rate. A few of them are Coronary Heart Disease, Chronic Liver Disease, and Chronic Kidney Disease.
- Many of the diseases listed are prevalent among older adults as age is a primary determinant.
- Although its prevalence is difficult to determine, it is believed that 50% of American adults have had Gingivitis, while 9%-17% of children within ages 3-14 currently have Gingivitis.
Introduction
This research contains the incidence rate, undiagnosed population, patient demographic, and the total amount spent on the diseases listed on rows 6-31 of the attached spreadsheet.
Selected Findings
- There are 18.2 million Americans aged 20 and above whom have Coronary Heart Disease. Also known as Coronary Artery Disease (CAD) or Ischemic Disease, it is more common in older adults and Hispanic Americans. The condition is often undiagnosed until a cardiac arrest or heart attack.
- About 94 million adults aged 20 or older and 7% of children and adolescents in the US currently live with Hyperlipidemia. The condition is prevalent among Non-Hispanic White females (14.8%) and Hispanic males (13.1%).
- According to the CDC, it is estimated that between 2.7 and 6.1 million Americans have Atrial Fibrillation. The risk of this disease is higher among older male adults as the possibility of occurrence increases with age. About 70% of people diagnosed with the condition are between ages 65 and 85.
- The incidence rate of Thrush, also known as Oral Candidiasis, is unavailable because there is no national surveillance for this infection in the US. However, the risk of Thrush has been proven to be higher among babies and people with underlying conditions such as diabetes, cancer, and HIV/AIDS.
Research Strategy
In answering this request, we leveraged fact sheets provided by the US Centre for Disease Control on each of the listed diseases. We also utilized other reputable sources such as the National Library of Medicine, the National Institute of Diabetes and Digestive and Kidney Diseases, and AHA Journals. However, some data points could not be provided as they are unavailable in the public domain. In some instances where the amount spent was deemed unavailable, we provided the total amount that the disease costs the US annually. We also could not cover all the diseases listed within the scope of this research. More research time is required to complete all cells of the spreadsheet.